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Abstract
Background: Recent development of mass spectrometry technology enabled the analysis of
complex peptide mixtures. A lot of effort is currently devoted to the identification of biomarkers
in human body fluids like serum or plasma, based on which new diagnostic tests for different
diseases could be constructed. Various biomarker selection procedures have been exploited in
recent studies. It has been noted that they often lead to different biomarker lists and as a
consequence, the patient classification may also vary.
Results: Here we propose a new approach to the biomarker selection problem: to apply several
competing feature ranking procedures and compute a consensus list of features based on their
outcomes. We validate our methods on two proteomic datasets for the diagnosis of ovarian and
prostate cancer.
Conclusion: The proposed methodology can improve the classification results and at the same
time provide a unified biomarker list for further biological examinations and interpretation.
Background
There is great hope among clinical proteomics researchers
that mass spectrometry (MS) will soon become a powerful
diagnostic tool. Extensive research has been conducted on
statistical learning methods for disease prediction from
MS data (see e.g. [1-9]). The data considered in this con-
text are mainly spectra of complex peptide mixtures, such
as plasma or serum samples. These spectra contain signals
of thousands of peptides. The dimension of the input
space is therefore very high, while the number of available
samples is relatively small (a few hundred at most). Fur-
thermore, only a small fraction of the peptides may poten-
tially be significant in determining the health state of the
patient. Most classification algorithms do not perform
well in this setting, and for the ones that do (e.g. random
forests) the results become difficult to interpret. Here we
consider two paradigms for reducing the dimension of the
data and identifying informative variables: feature selec-
tion and feature extraction. We review commonly used
feature selection and extraction procedures and propose a
new approach based on aggregating the preferences of sev-
eral competing methods.
Appropriate feature selection for mass spectrometry data
is crucial from diagnostic point of view. Selected peaks
from MS datasets corresponding to peptide signals should
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be further studied in order to identify functional relation-
ships and biological processes underlying the given dis-
ease. Peptides from proteins, which have clear
biochemical functionality, can be treated as biomarkers
for the disease. One typical approach to feature selection
is to rank the features according to the value of some sta-
tistic. We examine four popular feature ranking criteria (t-
statistic [10], mutual information [11], peak probability
contrasts [7] and random forest variable importance
measure [12]) and show that even though each of these
methods is intuitively compelling, they result in different
feature rankings (see Figure 1). Similar observations have
been made in [7] and [8]. This stands in contradiction
with the overall objective to use proteomic MS datasets for
identification of biomarkers specific of a given disease. It
is natural to postulate that one does not obtain many dif-
ferent biomarker lists for the same dataset. At the same
time it is not obvious, which single criteria best describes
a biomarker. We are inclined to assume that each scoring
function provides unique information about the varia-
bles. Therefore, we propose to take into account informa-
tion coming from various sources. This should also aid in
eliminating false positive biomarkers, as they are less
likely to be scored favorably by all of the distinct methods.
We present two novel solutions to the biomarker selection
problem, both of which aim at unifying the preferences of
a number of feature scoring functions. The first approach
is based on computing a consensus ranking, given the
individual rankings from several scoring functions. This is
often referred to as rank aggregation. This problem was
formulated in the context of the Web search engines in
[13] and several heuristics have been proposed therein for
this task. In our application the consensus is found as the
stationary distribution of an appropriately defined
Markov chain over the set of features.
A different way of reducing the dimension of the data is by
feature extraction. Instead of selecting a subset of the orig-
inal features, the aim is to construct a group of new fea-
tures that optimize a given objective. Often the method of
choice is principal component analysis (PCA), which
retains as much of the original variance of the data as pos-
sible, with the condition that the output variables are
uncorrelated. Typically PCA is applied to all of the varia-
bles to extract a small number of new variables, which
convey the greatest amount of the variance. We argue that
in the case of MS data (and many other similar applica-
tions) it is unrealistic to assume that the directions of the
greatest variance of the data capture the differences
between the observed health conditions. Instead many
other factors, independent of the given patient classifica-
tion, like age, diet, or sample processing may contribute to
the variance of the data. For best results and interpretabil-
ity we propose to apply PCA only to a selected group of
features. This selection is based on the outcome of a
number of scoring functions.
Results and discussion
We have evaluated our methods on two MS datasets. The
first dataset is a prostate cancer SELDI-TOF dataset pro-
vided by the Clinical Proteomics Program of the National
Cancer Institute. This dataset contains 322 samples (63
samples from healthy donors, 190 from patients with
benign prostatic hyperplasia (BPH), and 69 from patients
with prostate cancer). The motivation was to be able to
discriminate prostate cancer against other conditions,
therefore we have decided to classify these samples into
two groups: one with cancer samples and the other with
all the rest. We note that overall better classification accu-
racy can be achieved on this dataset with the exclusion of
BPH samples (data not shown). The second dataset used
in our experiments is a MALDI-TOF ovarian cancer dataset
from the Keck Laboratory at Yale University. We have
obtained a preprocessed version of this dataset by contact-
ing the authors of [8]. The dataset contains 91 samples
(47 cancer and 44 control). Each sample contains inten-
sity levels for 24262 peaks. All methods were evaluated by
ten fold cross-validation in which all the steps (feature
ranking, rank aggregation/PCA and supervised learning)
were repeated for each fold on the training part of the
samples. The average accuracy (fraction of samples cor-
rectly classified) is shown. Figures 2 and 3 show classifica-
tion results for the prostate cancer and ovarian cancer
datasets respectively.
Markov chain rank aggregation
To evaluate the performance of the Markov chain rank
aggregation algorithm we first scored each feature using
the four scoring functions, thus obtaining four rankings.
Next, we selected top 100 features from each list and
aggregated the resulting partial rankings using the Markov
chain method. Note that this process was repeated for
each training block of the data in the cross-validation
scheme. Best results were obtained using the MC4 transi-
tion matrix for the prostate cancer dataset and MC1 transi-
tion matrix in the case of the ovarian cancer dataset (the
respective transition matrices are defined in Section Meth-
ods). Figures 2 and 3 compare the classifier accuracy (total
number of correct class predictions divided by the total
number of predictions) obtained using different feature
selection methods and their aggregation for the two data-
sets. It can be observed that consensus ranking found by
the MC rank aggregation performed well compared to the
separate feature rankings. It did not achieve the highest
overall score, but was clearly better than most of the input
rankings it was computed from. In case of the prostate
cancer dataset (see Fig. 2) the classification accuracy for
features selected with MC4 closely followed the results for
the best input method, while all other input methods per-BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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Biomarker comparison Figure 1
Biomarker comparison. Best 10 peaks (i.e. peptide signals) from the Ovarian cancer dataset selected using PPC (left) and t-
statistics (right). Each small panel shows a histogram of peak heights in the training set at one m/z value for healthy patients 
(top) and cancer patients (bottom). Vertical line corresponds to the estimated optimal height split point (see [7] for details). 
The proportions of samples in each class having peaks higher than the split point are indicated (e.g. for top left corner panel 
these proportions are respectively 0.13 and 0.68). Notice that the two selected sets have only 3 peaks in common.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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Prostate cancer classification results Figure 2
Prostate cancer classification results. Classification results for four classifiers (random forest (RF), SVM, decision trees 
(DT) and LDA) on the SELDI-TOF prostate cancer dataset are shown separately in the four panels. Classifier performance 
using a specified number of best features from individual scoring functions (peak probability contrast (PPC), mutual information 
(MI), t-statistic (TT) and random forest feature ranking (RF)) are plotted in black. Performance with features selected by MC4 
rank aggregation of the four functions is shown in blue. Results for regular PCA and our modified "Consensus" version using 
only the best features from the four scoring functions are plotted in green and red respectively. For all methods the average 
accuracy (fraction of samples correctly classified) over 20 cross-validation runs is shown. See Section Results for discussion.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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Ovarian cancer classification results Figure 3
Ovarian cancer classification results. Classification results for four classifiers (random forest (RF), SVM, decision trees 
(DT) and LDA) on the MALDI-TOF ovarian cancer dataset are shown separately in the four panels. Classifier performance 
using a specified number of best features from individual scoring functions (peak probability contrast (PPC), mutual information 
(MI), t-statistic (TT) and random forest feature ranking (RF)) are plotted in black. Performance with features selected by MC1 
rank aggregation of the four functions is shown in blue. Results for regular PCA and our modified "Consensus" version using 
only the best features from the four scoring functions are plotted in green and red respectively. For all methods the average 
accuracy (fraction of samples correctly classified) over 20 cross-validation runs is shown. See Section Results for discussion.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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formed much worse. In case of the ovarian cancer data
(see Fig. 3), MC1 also outperformed three of four input
methods. Best features selected with the t-statistic yielded
the highest prediction accuracy on this dataset. However,
the accuracy of most classifiers significantly decreased
when more features from this ranking were used. The MC1
ranking displayed a more stable behavior increasing the
prediction accuracy as more features were included.
Consensus feature extraction via PCA
To evaluate the performance of the proposed consensus
feature extraction method, for each cross-validation split
we took a union of 100 best features from each ranking
and applied PCA to the data reduced to only those fea-
tures. A specified number of the outcome consensus fea-
tures (sorted by the decreasing eigenvalues) was chosen
each time to construct the classifier. Due to the limited
number of the input variables, PCA outputs only a small
number of significant features. We decided to take only
those which constitute for at least 0.1% of the variance.
The performance of standard PCA and the proposed
"Consensus" version for the two datasets are presented in
Figures 2 and 3. Features obtained from Consensus PCA
for the prostate cancer dataset (see Fig. 2) were far more
informative than the ones extracted using regular PCA
(judging by classifier performance). The accuracy
achieved using a small number of the consensus features
also compared favorably with the results for a large set of
features selected by the best input ranking function. In the
case of the ovarian cancer data using Consensus PCA sig-
nificantly improved the performance of the decision tree
classifier. Remaining classifiers yielded better predictions
using the standard PCA version. We also note that in the
case of this dataset using standard principal components,
which convey the variance of all features, overall resulted
in more accurate predictions than using features selected
by ranking methods (most evident with the SVM classi-
fier). Based on these observations we suspect that in the
case of this dataset lower ranked features provide addi-
tional information useful for class prediction. This would
explain the lower accuracy of the classifiers constructed
using the consensus features, which only convey informa-
tion about the top 100 features from each method.
Conclusion
We have proposed and tested two biomarker selection
methods: one based on rank aggregation and second
applying PCA to the informative variables selected by dif-
ferent scoring procedures. Both methods raise the possi-
bility of identifying predictors supported by several
competing feature ranking procedures. Although we
focused on the analysis of MS data, our methods can just
as well be applied to extract consensus predictors from
other large-scale experiments (e.g. gene expression micro-
array data).
In order to confirm the relevance of predictors found by
any computational means one must study their underly-
ing biological function. We are currently involved in two
proteomic projects carried out by the Laboratory of Mass
Spectrometry of the Polish Academy of Science and the
Warsaw Oncology Center, which aim at identifying prog-
nostic biomarkers for cystic-fibrosis and diagnostic
biomarkers for colorectal cancer. These studies will pro-
vide us a chance to validate our procedures with respect to
their ability to identify more biologically meaningful pre-
dictors and less false positives.
Methods
In this section we describe the main steps of our approach
(summarized in Figure 4). We focus our attention on fea-
ture selection and extraction for patient classification
based on MS data. In order to carry out the presented pro-
cedures the raw MS require preprocessing, which usually
includes background noise elimination, peak identifica-
tion and cross-sample peak alignment. These steps will
not be covered here (see e.g. [14-16] for methodological
description and software for processing raw MS data). We
will assume to work with an already preprocessed set of
samples.
We will denote our dataset with a p by n matrix, where p
is the number of intensity measurements and n  is the
number of samples. In a typical MS dataset the intensities
correspond to p mass to charge (m/z) ratios, which deter-
mine the set of observed variables. Sometimes additional
experimental techniques such as liquid chromatography
(LC) are applied to distinguish between substances with
the same mass, thus the observed variables may be further
refined by these measurements. The rows of the data
matrix contain the values of the observed variables (also
called features) for each of the n samples. Given a set of
training samples with known classification, our goal is to
build a classifier which will be able to predict the class of
a new sample. In the following discussion we will describe
the subsequent steps leading to the construction of a clas-
sifier which uses consensus features (potentially biomark-
ers) computed by one of our methods. These steps include
feature selection using various ranking functions, rank
aggregation or consensus feature extraction and super-
vised learning.
Biomarker selection by ranking functions
We begin by examining four feature selection methods.
The first one considered here is the t-statistic (TT) [10],
which measures the normalized differences of the means
of a given feature in two groups (e.g. cancer and healthy
group). The peak probability contrast method (PPC) for
classification of MS samples was introduced in [7]. Here
we exploit only the feature ranking part of the algorithm.
It proceeds by determining for each feature the split point,BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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Method overview Figure 4
Method overview. The control flow through different phases of the proposed method: we start with a preprocessed MS 
dataset; apply several competing biomarker selection procedures (t-statistic, peak probability contrasts (PPC), mutual informa-
tion and random forest feature ranking); achieve their consensus by the Markov chain rank aggregation method or PCA and 
train the classifiers (LDA, random forest, SVM, decision trees) on consensus features. For performance assessment the steps 
are repeated for each fold of the ten-fold cross-validation scheme.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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which maximally discriminates between the two given
groups of samples. The best split point is chosen among
the quantiles of feature values (i.e. peak heights at a given
position), (see [7] for details). As another way of deter-
mining feature importance, we consider the use of the
mutual information measure (MI) [11]. Each peptide sig-
nal is treated as a discrete source which conveys informa-
tion about the decision variable (class of the sample).
Features with the greatest mutual information with the
decision variable are considered the most important. The
forth ranking statistic considered here is the feature
importance measure computed by the random forest (RF)
classification algorithm [12]. Note that we also use ran-
dom forests as a classifier (see Section Classification).
The typical approach to feature selection would be to use
one of the above tests (or possibly a different method) to
rank all the variables using the training samples and select
top k of the variables (biomarkers) for further processing.
One serious drawback of this approach is that different
selection procedures result in different biomarker rank-
ings (see Figures 5 and 6) and yield different classification
rules. Each single selection method may provide valuable
information about the features. Therefore it is reasonable
to combine the information from several methods. In the
following we describe two methods for aggregating the
preferences of multiple scoring functions.
Markov chain rank aggregation
The first approach proposed here is to compute an aggre-
gated ranking from the outcomes of several feature selec-
tion procedures. The mathematical problem of rank
aggregation was originally formulated in the context of
Web search engines [13]. The idea is to start with several
partial rankings, and produce one consensus list being the
aggregation of them. Considered rankings are partial in
two senses: several features, consecutive in the ranking
list, can have the same label (i.e. they are equally ranked),
and often we are interested only in the top k items from
each list.
Rank aggregation problem has different formalizations
based on various optimality criteria. Probably one of the
most natural criteria – optimization of the average Kend-
all distance (the bubble sort distance between two lists)
has been proven to be NP-hard in [13]. To cope with the
complexity of the problem an efficient heuristic approach
based on calculating the stationary distribution of an
appropriately defined Markov chain has been proposed.
The states of the chain correspond to the features ranked
by various scoring functions and the transition probabili-
ties depend on the position of the features in the given
partial rankings. The aggregated consensus ranking is
obtained as the list of states sorted by their stationary
probabilities.
In this study we consider two Markov chains from [13]
(MC1  and MC4). The transition matrices for the two
Markov chains are defined as follows:
MC1 – If the current state is feature P, the next state is cho-
sen uniformly from the multiset of all features that were
ranked higher (or equal to) P by some feature selection
method that selected P. The main idea is that in each step
we move from the current feature to a better feature,
allowing about   probability of staying in the same state,
where k is roughly the average rank of the current feature.
MC4 – If the current state is P, then the next state is chosen
as follows: first pick a state Q uniformly from the union of
all ranked features. If Q is ranked better than P by the
majority of the methods, that selected both P and Q, then
go to Q, else stay in P.
In the case of chain MC1, we observed that its specific
structure complies well with the framework developed in
[17], where the Markov chain transition matrix L  is
assumed to have a form
L = L0 + ε·L1 + ε2·L2 + ... + εk·Lk,   (1)
for some parameter ε ∈ (0, 1). This structure reflects the
different strengths of interactions between the vertices of
the Markov chain underlying graph (see Figure 7), and
gives rise to an efficient algorithm for approximating the
stationary distribution. The approximation algorithm is
based on the idea of grouping together closely related
states. Different interaction strengths (transition probabil-
ities of the order of εn, n = 1 ... k from Eq. (1)) result in sev-
eral grouping phases. During the first grouping phase all
the top ranked features (the ones that were never ranked
lower than any other feature outside this group and have
transition probabilities between themselves above a cer-
tain threshold) are lumped together. Second phase con-
tinues with the smaller state space and determines the
next set of top ranked features, which are substituted by a
single clump in the third phase, etc. States which are
joined in the last phase have the lowest stationary proba-
bility. For each clump of grouped states the stationary dis-
tribution is calculated separately using the Grassmann-
Taksar-Heyman (GTH) algorithm [18] and appropriately
updated during the subsequent phases of the algorithm.
To ensure that all states will be grouped at some stage, we
set the transition probability from the top to the bottom
ranked features from each ranking list to a small value δ >
0. Recall that in the transition matrix of MC1 the probabil-
ities from lower ranked features to higher ranked are also
greater than 0. This ensures that the entire underlying
1
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Prostate cancer data ranking comparison Figure 5
Prostate cancer data ranking comparison. Rankings obtained from several feature selection methods for the Prostate can-
cer dataset. Each small panel shows the comparison of two rankings. A point with coordinates (i, j) corresponds to the feature 
with score i in one method and score j in the other (for all methods the most important features receive the highest scores). 
Values of the Spearman correlation coefficient for each pair of scoring functions are given in the panels above the diagonal. The 
random forest feature ranking (RF) is considerably different than the rest. Peak probability contrast method (PPC), mutual 
information (MI) and t-statistic (TT) share a common group of the highest scored features, but significant differences can be 
observed in ranks of less important features, which also provide valuable information for classification.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
Page 10 of 13
(page number not for citation purposes)
graph is strongly connected, which is a prerequisite of the
approximation algorithm. The probability value δ is cho-
sen appropriately to guarantee that the corresponding
interactions are taken into account during the last group-
ing phase, hence it has negligible influence on the final
result.
Ovarian cancer data ranking comparison Figure 6
Ovarian cancer data ranking comparison. Comparison of rankings obtained from several feature selection methods for 
the Ovarian cancer dataset. Each small panel shows the comparison of two rankings. A point with coordinates (i, j) corresponds 
to the feature with score i in one method and score j in the other (for each method the most important features receive the 
highest scores). Values of the Spearman correlation coefficient for each pair of scoring functions are given in the panels above 
the diagonal. Notice significant differences between various rankings even within the group of the highest scored features. RF 
ranking stands out the most as in the case of prostate cancer data.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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The structure of the graph underlying the Markov chain
MC1 is presented in Figure 7. Depicted is the nested family
of sets grouped together during the consecutive phases of
the algorithm.
Readers interested in the details of the approximation
algorithm are referred to [19], (an extended version of it is
available at [20]).
The hierarchical approach from [19] complies well with
chain MC1. The structure of MC4 does not allow for effi-
cient aggregation, but because of the limited number of
features selected from each input ranking, it is still tracta-
ble. Table 1 summarizes the efficiency of Markov chain
aggregation method. For MC1 we have 7 grouping stages;
the sizes of resulting groups vary from 4 to 87. For MC4 all
242 states are grouped together in the first phase and the
stationary distribution vector is calculated exactly using
the GTH algorithm [18]. The significant speed-up
obtained with the approximation algorithm is crucial
when aggregation is applied to complete rankings of fea-
tures from massive datasets.
Markov chain hierarchical structure Figure 7
Markov chain hierarchical structure. The structure of the state space graph for rank aggregation Markov chain MC1. The 
type of edge corresponds to the transition probability. Ellipses surround the top ranked features appearing in each phase (from 
1 up to 3 in this example). States joined at an earlier stage have higher stationary probability, and therefore rank higher in the 
aggregated ranking.BMC Bioinformatics 2007, 8(Suppl 5):S5 http://www.biomedcentral.com/1471-2105/8/S5/S5
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Consensus feature extraction
The second method proposed here is based on principal
component analysis (PCA) [21]. PCA is a projection
method, which seeks linear combinations of the original
variables with maximal variance. The i-th projection vec-
tor (orthogonal to all previous projection vectors) is given
by
where Σ is the covariance matrix. The solution to (2) is
given by the eigenvector of Σ, which corresponds to the i-
th largest eigenvalue. PCA is particularly useful for reduc-
tion and interpretation of biological data from high-
throughput technologies like mass spectrometry and
micro-arrays. It is an unsupervised method, so it does not
take into account the classification of the samples. As a
characteristic of high-throughput biological experiments,
large part of the variance of the data is possibly unrelated
to class assignments. Various biological and processing
factors can contribute to the overall diversity of the sam-
ples. Hence, for classification purposes, the aim should
not be to preserve the overall variance, but rather to pre-
serve the variance between classes. In order to boost the
discrimination power of the extracted features, we apply
PCA only to the group of the most discriminative varia-
bles. This also allows for easier interpretability of the
resulting features (i.e. determining the contributions of
the original variables), as the linear combinations are
taken over a much smaller set of vectors. We take the
union of the sets of top k features from each of the consid-
ered feature selection methods to generate the set of dis-
criminative features and apply PCA to the reduced data
matrix to extract a set of uncorrelated consensus features.
Classification
We use four well-known supervised learning algorithms
in our experiments, namely: linear discriminant analysis
(LDA), support vector machines (SVM), random forests
(RF), and decision trees (DT). All these methods have
been compared in [8]. We provide only a brief description
of SVM and RF below. For details and description of LDA
and DT see e.g. [22,23].
Support Vector Machines
Support Vector Machines were introduced by Vapnik [24].
The method seeks the optimal hyperplane separating two
classes. In the case of linearly separable data, the optimal
hyperplane can be found by solving a linear optimization
problem. Often the training points are not perfectly line-
arly separable. SVM deals with this problem by mapping
the data points into higher-dimensional space. For details
refer to [25].
Random forest
It has been found that aggregating classifiers built from
perturbed versions of the training set could substantially
improve prediction accuracy. Random forest ([12]) is a
very effective classifier which exploits this idea, by con-
structing an ensemble of classification trees and basing
the decision on the majority vote. Each tree is build on a
bootstrap sample of the training data and random feature
selection is applied at each node of the tree.
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Table 1: Markov chain grouping comparison.
MC # stages groups sizes time (in sec)
MC1 7 4, 15, 46, 51, 87, 14, 25 1.8
MC4 1 242 21.7
Performance of the hierarchical aggregation algorithm on two versions of the transition matrix (MC1 and MC4) for the Ovarian cancer dataset. For 
both considered Markov chains the number of phases, group sizes, and running times are given. In the case of MC1 the algorithm exploits the 
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